SERAFINI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 1.555
EU - Europa 1.495
AS - Asia 934
SA - Sud America 90
Continente sconosciuto - Info sul continente non disponibili 47
AF - Africa 25
OC - Oceania 2
Totale 4.148
Nazione #
US - Stati Uniti d'America 1.503
IT - Italia 375
RU - Federazione Russa 298
IE - Irlanda 235
SG - Singapore 230
CN - Cina 185
DE - Germania 172
SE - Svezia 129
BD - Bangladesh 116
VN - Vietnam 106
HK - Hong Kong 97
BR - Brasile 62
IN - India 60
FR - Francia 55
UA - Ucraina 53
GB - Regno Unito 51
FI - Finlandia 45
TR - Turchia 43
CA - Canada 32
JP - Giappone 19
IR - Iran 17
AR - Argentina 13
ES - Italia 11
MX - Messico 11
NL - Olanda 11
EE - Estonia 10
KR - Corea 10
PL - Polonia 9
ID - Indonesia 8
IQ - Iraq 7
BE - Belgio 6
CZ - Repubblica Ceca 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
BJ - Benin 5
LT - Lituania 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
CL - Cile 4
CO - Colombia 4
JM - Giamaica 4
PK - Pakistan 4
GR - Grecia 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
TW - Taiwan 3
AU - Australia 2
CI - Costa d'Avorio 2
EC - Ecuador 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
LU - Lussemburgo 2
MD - Moldavia 2
RO - Romania 2
SY - Repubblica araba siriana 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
CD - Congo 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
JO - Giordania 1
KH - Cambogia 1
LV - Lettonia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.103
Città #
Dublin 234
Ashburn 118
San Jose 105
Singapore 103
Hong Kong 93
Jacksonville 91
Council Bluffs 71
Los Angeles 59
Munich 58
Dearborn 56
Beijing 50
Chandler 50
New York 39
Piemonte 38
Turin 35
Wilmington 31
Dallas 29
Milan 29
Novara 29
Columbus 28
Ann Arbor 26
Hanoi 26
Santa Clara 26
Helsinki 24
Princeton 24
Lawrence 23
Moscow 23
Ho Chi Minh City 22
Bremen 21
Lauterbourg 21
Turku 20
Buffalo 19
San Mateo 19
Ankara 16
Vercelli 15
Orem 13
Phoenix 13
São Paulo 12
Chicago 11
Falkenstein 11
Montreal 11
Brooklyn 10
Frankfurt am Main 10
Rome 10
Tokyo 10
Da Nang 9
Hefei 9
Houston 9
Kocaeli 9
Toronto 9
Warsaw 9
Denver 8
Norwalk 8
Seattle 8
Zola Predosa 8
Calvisano 7
Chennai 7
Amsterdam 6
Andover 6
Bexley 6
Brno 6
Brussels 6
San Francisco 6
Ahmedabad 5
Ardabil 5
Atlanta 5
Cagliari 5
Cotonou 5
Guangzhou 5
Mexico City 5
Poplar 5
Reggio Emilia 5
Seoul 5
Tashkent 5
Woodbridge 5
Baghdad 4
Bari 4
Barnet 4
Biella 4
Boston 4
Charlotte 4
Chengdu 4
Fairfield 4
Figino 4
Jinan 4
Kingston 4
London 4
Manchester 4
Monroe 4
Mülheim 4
Palermo 4
Redondo Beach 4
Roubaix 4
Shanghai 4
Shenyang 4
Stockholm 4
Tianjin 4
Treviso 4
Zanjan 4
Augusta 3
Totale 2.077
Nome #
Discovery and development of small molecules targeting IDO1 and SOCE 555
Click 1,2,3-triazoles in drug discovery and development: From the flask to the clinic? 335
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 173
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 164
Drug Discovery for Soft Drugs on TRPV1 and TRPM8 Channels Using the Passerini Reaction 164
A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies 155
Applications of deuterium in medicinal chemistry 152
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs 150
Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors 148
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs 140
A primer of deuterium in drug design 140
Synthesis, biological evaluation and molecular docking of Ugi and Passerini products as novel indoleamine 2,3-dioxygenase 1 inhibitors 135
A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability 135
The use of 2-hydroxymethyl benzoic acid as an effective water surrogate in the Passerini reaction: A straightforward access to α-hydroxyamides 134
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry 130
Arynes and isocyanides: Two close-knit partners in multicomponent reactions 125
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy 123
An aryne-based three-component access to α-aroylamino amides 123
Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors 120
SOCE: EMERGE UN NUOVO TARGET TERAPEUTICO DAL “CALCIUM TOOLKIT” DELLA CELLULA 119
The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors 114
The 115 Year Old Multicomponent Bargellini Reaction: Perspectives and New Applications 110
What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications 109
STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39 101
An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline 99
Soft drugs for dermatological applications: recent trends 98
Tritylamine as an ammonia surrogate in the ugi reaction provides access to unprecedented 5-sulfamido oxazoles using burgess-type reagents 97
Totale 4.148
Categoria #
all - tutte 16.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022236 0 11 30 34 10 3 10 6 12 43 23 54
2022/2023590 25 27 40 13 55 49 33 36 257 9 33 13
2023/2024186 19 21 20 4 26 3 40 11 6 1 13 22
2024/2025512 11 25 41 15 26 49 50 47 77 32 30 109
2025/20261.644 95 58 78 221 149 94 160 229 94 165 158 143
2026/2027458 371 87 0 0 0 0 0 0 0 0 0 0
Totale 4.148